Conclusion
In general, regarding different recommendations for corticosteroids use by various guidelines and authorities, the ultimate decision for corticosteroid therapy in a COVID-19 patient is primarily based on physicians’ judgments and the patient’s condition. The application of corticosteroids requires special attention to the benefit-risk relationships and the adjustment of doses if necessary. It is mandatory to monitor signs of hyperglycemia, adrenal insufficiency, and secondary bacterial and fungal infections in the context of glucocorticoid therapy.